Quantcast

Latest Monoclonal antibodies Stories

2015-02-02 08:30:31

SAN DIEGO, Feb. 2, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2015-01-29 08:32:05

-33% rate of DAS28-CRP remission or low disease activity reported in Phase 2a cohort- MONROVIA, Calif., Jan. 29, 2015 /PRNewswire/ -- Xencor, Inc.

2015-01-29 08:32:00

- 90% of subjects had reduction of free IgE to below the limit of detection by the end of XmAb7195 infusion, including at lowest dose evaluated of 0.3 mg/kg - MONROVIA, Calif.,

2015-01-28 08:32:02

SAN DIEGO, Jan. 28, 2015 /PRNewswire/ -- Sorrento Therapeutics, Inc.

2015-01-26 00:20:42

TARRYTOWN, N.Y. and PARIS, Jan. 26, 2015 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced that the U.S.

2015-01-22 08:30:07

LONDON, January 22, 2015 /PRNewswire/ -- Report Details Treating Crohn's disease and ulcerative colitis - how to find R&D trends, opportunities and revenue

2015-01-16 23:03:36

Researchmoz.us announces new research report on Antibody Partnering Terms and Agreements to it's huge collection.


Word of the Day
deuteragonist
  • A person in a secondary role, specifically the second most important character (after the protagonist).
The word 'deuteragonist' comes from a Greek word meaning 'an actor of second-class parts'.
Related